Solingen, Germany

Rudi Grützmann


Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
8 patents (USPTO):

Title: Rudi Grützmann: Innovator in Medicinal Chemistry

Introduction

Rudi Grützmann is a prominent inventor based in Solingen, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 8 patents. His work focuses on developing innovative compounds that have potential applications in the medical field.

Latest Patents

Grützmann's latest patents include the development of cycloalkano-indole and -azaindole derivatives. These compounds are synthesized through the reaction of appropriately substituted carboxylic acids with amines. The cycloalkanoindole and -azaindole derivatives are particularly noteworthy for their suitability as active compounds in medicaments, especially those aimed at combating atherosclerosis. Another significant patent involves hetero-linked phenylglycinolamides, which are prepared by reacting the corresponding hetero-linked phenylacetic acids with appropriate phenylglycinols. These compounds also show promise as active ingredients in various medicaments.

Career Highlights

Rudi Grützmann is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on innovative research and development in the field of medicinal chemistry.

Collaborations

Throughout his career, Grützmann has collaborated with notable colleagues, including Ulrich Müller and Hilmar Bischoff. These collaborations have further enhanced his research and contributed to the advancement of medicinal compounds.

Conclusion

Rudi Grützmann's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His innovative work continues to pave the way for new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…